Company: PFSA
Filing Date: 2025-08-22
Form Type: S-1/A
Source: 0001213900-25-079829
Chunk: 144

Company: Profusa, Inc.
Filing Date: 2025-08-22
Form: S-1/A
Chunk 144
---
 the final amounts recorded may differ materially from the information presented. The unaudited pro forma condensed combined financial information does not give effect to any anticipated synergies, operating efficiencies, tax savings or cost savings that may be associated with the Business Combination. In addition, on July28, 2025, we entered into the Committed Equity Facility with Ascent, pursuant to which Ascent has committed to purchase up to $100,000,000 of shares of our Common Stock, subject to certain limitations and conditions set forth in the Purchase Agreement. The shares of our Common Stock that may be issued under the Purchase Agreement may be sold by us to Ascent at our discretion from time to time for a period of up to 36months (unless the Purchase Agreement is earlier terminated) beginning on the Effective Date. The proceeds from the Committed Equity Facility are to be used exclusively for the purchase of Bitcoin (which may be used for repayment of indebtedness), provided the Company’s cash balance on any Closing Date exceeds $5,000,000. If the cash balance is less than $5,000,000, proceeds must first be used to bring the cash balance to that amount, with the remainder used to purchase Bitcoin. The unaudited pro forma condensed combined financial information is not necessarily indicative of what the actual results of operations and financial position would have been had the Business Combination taken place on the dates indicated, nor are they indicative of the future consolidated results of operations or financial position of the Combined Company. They should be read in conjunction with the historical financial statements and notes thereto of NorthView and Profusa. The accompanying pro forma financial statements reflect the impact of transactions that are either completed or considered probable in accordance with Regulation S -XArticle 11. Management has considered the impact of the Committed Equity Facility on these pro forma financial statements, and notes that the agreement is written in a manner in which the Company will issue a variable number of shares at a variable issuance price, based on the then current market rates, less a fixed discount. Accordingly, inclusion of the transaction in the pro forma common stock financial information would not be factually supportable or objectively measurable at this time and could be misleading to investors. Pursuant to the Purchase Agreement, 900,000 Commitment Warrant Shares are issuable upon exercise of the Commitment Warrants we issued to Ascent upon our execution of the term sheet relating to the Purchase Agreement on July20, 2025, as consideration for its commitment to purchase shares of our Common Stock that we may